Comparison
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197 vs 46 Xx Gonadal Dysgenesis C0685837
Clinical comparison between 46 XX Disorder OF Sex Development Induced BY Maternal Derived Androgen and 46 XX Gonadal Dysgenesis for differential diagnosis and treatment planning.
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
A condition where androgens from the pregnant person cross to the fetus, causing atypical genital development in an XX baby. It ranges from mild to severe. Specialists guide hormone and surgical management.
46 Xx Gonadal Dysgenesis C0685837
A condition affecting ovarian development in individuals with two X chromosomes. May impact puberty and fertility. Treatment typically includes hormone replacement and supportive care.
6 comparison axes
Onset
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
0-0
46 Xx Gonadal Dysgenesis C0685837
12-16
Onset patterns differ
Severity
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
severe
46 Xx Gonadal Dysgenesis C0685837
moderate
Different severity levels
Chronic
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
Chronic
46 Xx Gonadal Dysgenesis C0685837
Chronic
Differing course
Communicable
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
No
46 Xx Gonadal Dysgenesis C0685837
No
Different transmission
Body System
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
reproductive
46 Xx Gonadal Dysgenesis C0685837
reproductive
Same/different system
Category
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
endocrine
46 Xx Gonadal Dysgenesis C0685837
genetic
Different category
Bottom line
46-xx-disorder-of-sex-development-induced-by-maternal-derived-androgen-C5680197 and 46-xx-gonadal-dysgenesis-C0685837 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197 | 46 Xx Gonadal Dysgenesis C0685837 | Discriminating power |
|---|---|---|---|
| Genital appearance at birth | Atypical genital development may be present and can range from mild to marked. | External genitalia are often typical; atypical appearance is not the defining feature. | Moderate |
| Pubertal development | Puberty may occur, but androgen effects and management needs vary. | Delayed or absent puberty and primary amenorrhea may occur. | Moderate |
| Timing of recognition | Often considered around birth because of atypical genital findings. | Often considered around expected puberty, roughly ages 12–16. | High |
When to favor each condition
Choose 46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197 when
XX infant with atypical genitalia and possible maternal androgen source
The history points toward prenatal androgen exposure rather than primary gonadal failure.
Moderate
Known maternal androgen-producing condition or exogenous androgen exposure
A documented maternal source supports this endocrine mechanism.
High
Early-life endocrine evaluation is required
Hormone assessment and specialist review help distinguish exposure from other DSD causes.
Moderate
Choose 46 Xx Gonadal Dysgenesis C0685837 when
46,XX adolescent with absent or incomplete puberty
This pattern fits impaired ovarian development more than prenatal androgen exposure.
Moderate
Primary amenorrhea with suspected streak or dysgenetic gonads
Gonadal assessment is central when ovarian development is impaired.
Moderate
No maternal androgen source is identified
Absence of an exposure history makes gonadal dysgenesis relatively more plausible.
Low
How key tests differ
| Test | 46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197 | 46 Xx Gonadal Dysgenesis C0685837 | Interpretation |
|---|---|---|---|
| Karyotype | 46,XX by definition of the concept. | 46,XX by definition of the concept. | Karyotype does not separate these conditions. |
| Maternal and pregnancy androgen history | A maternal androgen source may be identified. | No maternal androgen source is expected. | History is supportive but not independently diagnostic. |
| Gonadal and pubertal endocrine assessment | Gonads may be present; findings depend on exposure and age. | Impaired ovarian development or streak gonads may be found. | Imaging and hormone results need clinician correlation; cutoffs are not established here. |
Prognosis comparison
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
- Outcome
- Variable; ranges from mild to severe effects, with outcomes not quantified here.
- Factors
- Degree of androgen exposure, genital findings, and access to specialist care.
46 Xx Gonadal Dysgenesis C0685837
- Outcome
- Often involves ongoing pubertal and fertility concerns; exact outcomes are not established here.
- Factors
- Extent of gonadal dysgenesis, hormone treatment, and associated conditions.
Time frame: From birth or adolescence into adult follow-up.
Accurate etiology, timely endocrine care, and psychosocial support influence management.
Complications comparison
| Complication | Presentation |
|---|---|
| Fertility impact | Fertility potential is variable and not established from this description alone. Fertility is commonly affected because ovarian development is impaired. Counseling should be individualized. |
| Hormone-related needs | Androgen effects may require endocrine follow-up. Hormone replacement is typically considered for pubertal support. No dose or regimen should be inferred. |
| Psychosocial burden | Genital difference and decisions about care may cause distress. Delayed puberty, infertility concerns, and identity issues may cause distress. Supportive, nonjudgmental care is important. |
Patient education highlights
- HighDiagnosis is specialist-led
An abnormal finding or karyotype result is not a complete diagnosis; endocrine and genetics clinicians should interpret it.
- HighDifferent mechanisms
One condition involves prenatal maternal androgen exposure; the other involves impaired ovarian development.
- MediumLong-term care
Both are chronic and may need hormone, fertility, surgical, and psychosocial support tailored to the person.